Minimal clinically important differences for measures of treatment efficacy in Stevens-Johnson syndrome and toxic epidermal necrolysis - 10/11/18
Doi : 10.1016/j.jaad.2018.06.002
Whan B. Kim, MD a, Brandon Worley, MD, MSc a, James Holmes, MD b, Elizabeth J. Phillips, MD, FRCPC, FACP c, d, Jennifer Beecker, MD, CCFP(EM), FRCPC, DABD a, ⁎ 
a Division of Dermatology, Department of Medicine, University of Ottawa, Ottawa, Canada
b Wake Forest University School of Medicine, Ottawa, Canada
c Department of Medicine, Vanderbilt University Medical Center, Ottawa, Canada
d Institute for Immunology & Infectious Diseases, Murdoch University, Ottawa, Canada
∗Reprint requests: Jennifer Beecker, MD, CCFP(EM), FRCPC, DABD, Division of Dermatology, Department of Medicine, University of Ottawa, The Ottawa Hospital Civic Campus, 4th Floor, 737 Parkdale Ave, Ottawa, Ontario K1Y-1J8, CanadaDivision of DermatologyDepartment of MedicineUniversity of OttawaThe Ottawa Hospital Civic Campus, 4th Floor, 737 Parkdale AveOttawaOntarioK1Y-1J8Canada
| Funding sources: None. |
|
| Conflicts of interest: None disclosed. |
© 2018
American Academy of Dermatology, Inc.. Pubblicato da Elsevier Masson SAS. Tutti i diritti riservati.
Vol 79 - N° 6
P. 1150-1152 - dicembre 2018 Ritorno al numero
Articolo precedente
- Anti-aging effects of ingenol mebutate for patients with actinic keratosis
- Miri Kim, Yujin Jung, Jongsic Kim, Seo-won Jeong, Yu Ri Woo, Hyun Jeong Park
- 12-Hydroxyeicosatetraenoic acid levels are increased in actinic keratoses and squamous cell carcinoma
- Vivian Laquer, Ryan W. Dellinger, Irene Mannering, Angela Gomez Garcia, Vivek Abraham, Janelle Pavlis, Feng Liu-Smith, Sebastien De Feraudy, Frank L. Meyskens, Kristen M. Kelly
Benvenuto su EM|consulte, il riferimento dei professionisti della salute.
L'accesso al testo integrale di questo articolo richiede un abbonamento.
Già abbonato a @@106933@@ rivista ?